Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horizon Sopyrwa is a Rwandan biotechnology and manufacturing company specializing in the production of natural pyrethrum, a potent botanical insecticide derived from Chrysanthemum cinerariaefolium flowers. As a subsidiary of Horizon Group, the company operates a sophisticated refinery in Musanze that processes dried flowers into high-quality pyrethrum pale extract for the global market. Its products are critical components in public health initiatives, particularly for vector control in the prevention of malaria and other insect-borne diseases. The company maintains a vertically integrated supply chain, collaborating with thousands of smallholder farmers to ensure sustainable sourcing and high-purity chemical output suitable for pharmaceutical and household applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Horizon Sopyrwa.